WO1996031132A1 - Health beverage - Google Patents
Health beverage Download PDFInfo
- Publication number
- WO1996031132A1 WO1996031132A1 PCT/CN1996/000022 CN9600022W WO9631132A1 WO 1996031132 A1 WO1996031132 A1 WO 1996031132A1 CN 9600022 W CN9600022 W CN 9600022W WO 9631132 A1 WO9631132 A1 WO 9631132A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- astragalus
- zinc
- beverage
- salvia
- Prior art date
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 26
- 230000036541 health Effects 0.000 title claims abstract description 7
- 235000017276 Salvia Nutrition 0.000 claims abstract description 11
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 11
- 239000011719 vitamin A Substances 0.000 claims abstract description 11
- 241001072909 Salvia Species 0.000 claims abstract description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 7
- 229940045997 vitamin a Drugs 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims description 25
- 241001061264 Astragalus Species 0.000 claims description 24
- 210000004233 talus Anatomy 0.000 claims description 24
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 16
- 239000011701 zinc Substances 0.000 claims description 16
- 229910052725 zinc Inorganic materials 0.000 claims description 16
- 235000016804 zinc Nutrition 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 244000298697 Actinidia deliciosa Species 0.000 claims description 12
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 12
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- WGPCGCOKHWGKJJ-UHFFFAOYSA-N sulfanylidenezinc Chemical compound [Zn]=S WGPCGCOKHWGKJJ-UHFFFAOYSA-N 0.000 claims description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000010025 steaming Methods 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 3
- 150000002632 lipids Chemical class 0.000 abstract description 3
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 150000003752 zinc compounds Chemical class 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 8
- 244000132619 red sage Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 4
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000282553 Macaca Species 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229960001763 zinc sulfate Drugs 0.000 description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000009525 Myocarditis Diseases 0.000 description 2
- ZKXDGKXYMTYWTB-UHFFFAOYSA-N N-nitrosomorpholine Chemical compound O=NN1CCOCC1 ZKXDGKXYMTYWTB-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical compound NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001597 anti-proteinuria Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001158 estrous effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- -1 lipid peroxides Chemical class 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940104757 vitamin E 50 mg Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to the field of beverages, in particular to health drinks with traditional Chinese medicine Astragalus and Salvia miltiorrhiza as main raw materials. BACKGROUND OF THE INVENTION
- the raw materials Astragalus membranaceus and Salvia miltiorrhiza used in the beverage of the present invention are medicinal materials used in traditional Chinese medicine.
- Astragalus has the effect of delaying aging. After human fetal kidney cells and mouse kidney cells are cultured into a single layer, adding 0.5% astragalus to the culture medium can increase the number of living cells, the cells grow vigorously, and the cell life can be extended by about 1 time, which can extend human embryo lung The natural aging process of ploidy cells prolongs the lifespan of the cells by about 1/3, and extends the natural senescent cells from 61 to 88 to 89 generations. Astragalus has the effect of enhancing immunity and can induce the activity of interferon and NK cells.
- Astragalus can promote the synthesis of liver RNA and DNA, increase the content of cyclic adenosine monophosphate (cAMP) in plasma, increase the endurance of the body, double the swimming time of experimental rats, and promote the generation, development and maturation of various blood cells.
- cAMP cyclic adenosine monophosphate
- Hematopoietic function of bone marrow which has the function of lowering blood pressure and improving skin blood circulation, can extend the estrous period of mice by 10 times, enhance the learning and memory ability of mice, have the effect of inhibiting sweating and anti-proteinuria, and make the whole blood viscosity of elderly rats , Serum viscosity, hematocrit decreased, astragalus contains iron, manganese, zinc, gallium and thallium and other elements. It has the function of reducing cancer, reducing lipid hyperoxidation and scavenging free radicals.
- Salvia miltiorrhiza promotes blood flow speed and microcirculation, reduces blood viscosity, inhibits calcium ion cell influx, inhibits inflammation, and eliminates free radicals and lipid peroxides.
- Reduce sterols, stop arteriosclerosis and clear atherosclerotic lumps protect the heart and brain from air loss and promote regeneration and repair, promote the regeneration of liver, fractures and blood transfer functions, stop liver damage and liver hardening.
- the raw material kiwi of the present invention contains more than ten kinds of arginic acid and various quantity elements, and the content of biotin C is several tens of times more than that of other fruits. Tests show that after obliteration, its carcinogenic blocking rate to N-nitrosomorpholine is 94.4%. Clinical observations of kiwi fruit juice in 24 patients with hypertension, angina pectoris, arrhythmia, cerebrovascular disease, and hyperlipidemia of different etiology were performed on 24 men and women with 50-70% of men and women. Steroids decreased by P ⁇ 0.01, ⁇ -lipoprotein decreased by P ⁇ 0.01, and glycerol S decreased by P ⁇ 0.05, with significant differences. The step-down effective rate is 100%. Kiwi also contains vitamin P, which also plays a role in lowering blood pressure.
- Zinc participates in the synthesis and metabolism of more than 100 enzymes in the body, and the activities of gonads, pancreas and pituitary gland all have zinc. Zinc has the effects of promoting development, improving taste, etc. When zinc is deficient, growth stagnation, reproductive incompetence, and the body are weak. Zinc deficiency causes abnormal development of the sexual organs and sperm, and hypofunction leads to male infertility. Zinc can improve the body's immunity and stimulate the thymus to secrete adenine, which in turn can activate the body's immune cells.
- the beverage involving astragalus and salvia miltiorrhiza as the main raw material of the present invention is a health-care beverage.
- the combined effect of astragalus and salvia miltiorrhiza not only shows the health effects of their respective ingredients, but also interacts with each other to produce unexpected positive effects.
- the beverage of the present invention also includes adding kiwi juice and various vitamins and zinc to astragalus and salvia, and combining Chinese and Western to comprehensively supplement various nutritional components necessary for enhancing human body functions.
- the beverage of the present invention combines the positive effects of each component, and has the ability to adjust the body's yin-yang balance, improve the body's immunity and endurance, reduce blood viscosity, and speed up blood flow. Lipid overdose reaction and free radical production can protect the heart and cerebellar canal disease and cancer in middle-aged and elderly people, and can delay cells I am old.
- the vitamins contained in the beverage of the present invention include vitamins A, C, E and; the added zinc is a soluble inorganic zinc salt such as sulfur zinc. Macaque picks are natural, fresh fruits.
- the weight content of each component of the present invention per 200 ml of beverage includes: astragalus 3-30g
- Vitamin E 50 lOOmg
- the rest is water.
- sugar can be added according to taste and needs.
- the sugar includes white sugar, protein sugar or other sweeteners, and the added amount is determined as needed, such as according to the calorie requirements of the drinker. It is well known to those skilled in the art to make high-calorie beverages and low-calorie beverages, and to add a certain amount of additives commonly used in the beverage field such as honey to the beverages of the present invention.
- the health drink of the present invention can be prepared according to the following process:
- steps a and b Mixing the products of steps a and b, adding the required amounts of vitamins A, C, E and zinc, and adding the required water to mix well, and adding additives such as sugar and honey as needed, and sterilizing to obtain the health drink of the present invention.
- the disinfection method may be high temperature disinfection, or Roentgen ray radiation or sign wave disinfection.
- the present invention will be described in more detail with specific examples.
- Zinc sulfate lOmg (based on zinc content)
- the amount of astragalus and salvia was shredded, 80g of steamed water was added, and it was cooked to about 20g, and 72g of 95% alcohol was added, left for 48 hours, filtered, and concentrated to a 1: 1 concentrated solution.
- the amount of kiwi is washed and peeled, mashed into a pulp by a masher, centrifuged, and filtered to obtain a clear raw juice;
- Zinc sulfate 8mg (based on zinc content)
- Zinc sulfate 8mg (based on zinc content)
- 200ml of the beverage of the present invention is prepared by the above-mentioned ingredients in a similar manner to that in Embodiment 1.
Abstract
This invention relates to a health beverage which contains Astragagus membranaceas and Salvia miltiorrhize Bge as main ingredients, in combination with vitamin A, C, E, et B6 and a zinc compound as additional ingredients. The beverage not only has such functions as anti-aging, anti-cancer and anti-arteriosclerosis but also is capable of being against the lipid peroxidization and reducing the generation of free radicals.
Description
保健饮料 发明的技术领域 TECHNICAL FIELD
本发明涉及饮料领域，特别是以中药黄芪和丹参为主要原料的 保健饮料。 发明的背景技术 The present invention relates to the field of beverages, in particular to health drinks with traditional Chinese medicine Astragalus and Salvia miltiorrhiza as main raw materials. BACKGROUND OF THE INVENTION
本发明饮料中使用 原料黄芪和丹参是传统中医中使用的葯 材。 The raw materials Astragalus membranaceus and Salvia miltiorrhiza used in the beverage of the present invention are medicinal materials used in traditional Chinese medicine.
黄芪有延緩衰老的作用。人胎肾细胞和小鼠肾细胞培养成单层 后，在培养液中加 0. 5%黄芪，可使活细胞数增多，细胞生长旺盛， 细胞寿命延长 1倍左右，可延长人胚肺二倍体细胞的自然袞老过 程，延长细胞寿命 1/3左右，使自然衰老的细胞由 61代延长到 88 〜89代。 黄芪具有增强免疫的作用，能诱导丫干扰素及促 NK细胞 的活性。 对流感病毒和心肌炎病毒（柯荫奇 B3病毒）感染者有显著 的防护作用，使其不致心肌炎或减轻心肌的损害。 黄芪能促进肝脏 RNA和 DNA的合成，提高血浆环磷酸腺普（cAMP)的含量，增强机 体耐力，使实验大鼠游泳时间增加 1倍,能促进各类血细胞的生成， 发育及成熟过程，促进骨髓的造血机能，具有降压和改善皮肤血液 循环 用，能延长小鼠动情期 10倍时间，增强小鼠学习和记忆能 力，有抑制发汗和抗蛋白尿作用，使老年大鼠的全血粘度，血清粘 度，红细胞压积下降，黄芪含有铁、锰、锌、镓和踊等徵量元素。 具 有昉癌，减少脂质过氡化和清除自由基的作用，其抗过氡化能力是 维生素 E的 500倍，而且黄芪绝不会出现补品中毒现象（如人参可 中毒），它具有异於一般补品无可比拟的阴阳双向调节作用，即对阳 盛阴虛者平阳扶阴，对阳袞阴盛者能壮阳平阴，所以对任何体质的 人都适用。 Astragalus has the effect of delaying aging. After human fetal kidney cells and mouse kidney cells are cultured into a single layer, adding 0.5% astragalus to the culture medium can increase the number of living cells, the cells grow vigorously, and the cell life can be extended by about 1 time, which can extend human embryo lung The natural aging process of ploidy cells prolongs the lifespan of the cells by about 1/3, and extends the natural senescent cells from 61 to 88 to 89 generations. Astragalus has the effect of enhancing immunity and can induce the activity of interferon and NK cells. It has a significant protective effect on those infected with influenza virus and myocarditis virus (Coyin B 3 virus), so that it will not cause myocarditis or reduce myocardial damage. Astragalus can promote the synthesis of liver RNA and DNA, increase the content of cyclic adenosine monophosphate (cAMP) in plasma, increase the endurance of the body, double the swimming time of experimental rats, and promote the generation, development and maturation of various blood cells. Hematopoietic function of bone marrow, which has the function of lowering blood pressure and improving skin blood circulation, can extend the estrous period of mice by 10 times, enhance the learning and memory ability of mice, have the effect of inhibiting sweating and anti-proteinuria, and make the whole blood viscosity of elderly rats , Serum viscosity, hematocrit decreased, astragalus contains iron, manganese, zinc, gallium and thallium and other elements. It has the function of reducing cancer, reducing lipid hyperoxidation and scavenging free radicals. Its anti-hypercancelation ability is 500 times that of vitamin E, and astragalus will never appear tonic poisoning (such as ginseng poisoning), which is different from General tonics have incomparable yin-yang two-way regulation effect, that is, for those with yang-yin deficiency and yin-yang, they can strengthen yang and yin-yang, so it is suitable for anyone with any constitution.
丹参的主要劝能是促进血流速度和微循环，减少血液粘度，抑 制钙离子细胞内流，抑制炎症的发生，清除自由基和脂质过氡化物，
降低脬固醇，昉止动脉硬化和清除已粥样硬化的 ^块，保护心脑缺 氣时的损害和促进再生与修复，促进肝脏，骨折和迻血机能的再生， 昉止肝损害和肝硬化。 Salvia miltiorrhiza promotes blood flow speed and microcirculation, reduces blood viscosity, inhibits calcium ion cell influx, inhibits inflammation, and eliminates free radicals and lipid peroxides. Reduce sterols, stop arteriosclerosis and clear atherosclerotic lumps, protect the heart and brain from air loss and promote regeneration and repair, promote the regeneration of liver, fractures and blood transfer functions, stop liver damage and liver hardening.
本发明的原料猕猴桃中含有十多种氩基酸和多种徵量元素，其 中徵生素 C的含量是其它果品的几十倍以上。 试验表明，在经过晦 氡化后，其对 N—亚硝基吗啉的致癌阻断率为 94. 4 %。 经对 24例 50- 70穸的男女高血压，心绞癍，心率不齐，脑血管疾病和不同病 因的高血脂患者进行饮用猕猴桃果汁临床观察，结果取得了明显的 疗效，服用前后比较，脬固醇下降 Ρ<0. 01，β—脂蛋白下降 Ρ<0. 01 ,甘油 S旨下降 Ρ<0. 05，差异显著。 降压有效率为 100%。 猕猴桃 还含有维生素 Ρ，其对降压也有一定作用。 The raw material kiwi of the present invention contains more than ten kinds of arginic acid and various quantity elements, and the content of biotin C is several tens of times more than that of other fruits. Tests show that after obliteration, its carcinogenic blocking rate to N-nitrosomorpholine is 94.4%. Clinical observations of kiwi fruit juice in 24 patients with hypertension, angina pectoris, arrhythmia, cerebrovascular disease, and hyperlipidemia of different etiology were performed on 24 men and women with 50-70% of men and women. Steroids decreased by P <0.01, β-lipoprotein decreased by P <0.01, and glycerol S decreased by P <0.05, with significant differences. The step-down effective rate is 100%. Kiwi also contains vitamin P, which also plays a role in lowering blood pressure.
锌参与体内 100多种酶的合成与代谢，性腺、胰腺、脑下垂体的 活动都有锌的参与。锌具有促进发育，改善味觉等作用，缺锌时生长 停滞，生殖无能，机体袞弱。 缺锌导致性器官和精子发育不正常，性 机能减退引起男性不育。 锌能提高机体的免疫力，激发胸腺分泌腺 素，胸腺素又能激活机体的免疫细胞。 Zinc participates in the synthesis and metabolism of more than 100 enzymes in the body, and the activities of gonads, pancreas and pituitary gland all have zinc. Zinc has the effects of promoting development, improving taste, etc. When zinc is deficient, growth stagnation, reproductive incompetence, and the body are weak. Zinc deficiency causes abnormal development of the sexual organs and sperm, and hypofunction leads to male infertility. Zinc can improve the body's immunity and stimulate the thymus to secrete adenine, which in turn can activate the body's immune cells.
现有技术中，以黄芪和丹参为主料的饮料鲜见报道，而仅有黄 芪和丹参与其它中药合配使用来治疗相关疾病。将其与维生素等合 用作为保健用品还没有报道。 本发明的公开 In the prior art, beverages containing Astragalus and Danshen as raw materials are rarely reported, and only Astragalus and Dan participate in the combined use of other traditional Chinese medicines to treat related diseases. It has not been reported as a health product in combination with vitamins. Disclosure of the present invention
本发明涉及的以黄芪和丹参为主要原料的饮料是一种保健型 饮料，黄芪和丹参的合配作用，不仅显示其各自成份的保健作用，且 相互作用，产生意想不到的积极效果。此外，本发明的饮料还包括在 黄芪和丹参中加入猕猴桃原汁和各种维生素及锌，中西结合，全面 补充增强人体机能所必需的各种營养成分。 The beverage involving astragalus and salvia miltiorrhiza as the main raw material of the present invention is a health-care beverage. The combined effect of astragalus and salvia miltiorrhiza not only shows the health effects of their respective ingredients, but also interacts with each other to produce unexpected positive effects. In addition, the beverage of the present invention also includes adding kiwi juice and various vitamins and zinc to astragalus and salvia, and combining Chinese and Western to comprehensively supplement various nutritional components necessary for enhancing human body functions.
本发明饮料的结合了每种組份的积极作用，具有调整机体阴阳 平衡，提高机体免疫力和耐力，减小血液粘度，加快血流速度， Ρ方止 动脉粥样硬化和血管栓塞，减少机体脂质的过氡化反应和自由基的 产生，对中老年人心脑丘管疾病和癌病有防护作用，并能延锾细胞
衮老。 The beverage of the present invention combines the positive effects of each component, and has the ability to adjust the body's yin-yang balance, improve the body's immunity and endurance, reduce blood viscosity, and speed up blood flow. Lipid overdose reaction and free radical production can protect the heart and cerebellar canal disease and cancer in middle-aged and elderly people, and can delay cells I am old.
本发明的饮料中所含维生素包括维生素 A，C，E和 ;所加入 的锌为可溶性无机锌盐如硫駿锌。 猕猴挑为天然新鲜果品。 The vitamins contained in the beverage of the present invention include vitamins A, C, E and; the added zinc is a soluble inorganic zinc salt such as sulfur zinc. Macaque picks are natural, fresh fruits.
本发明各組份的重量含量以每 200毫升饮料计包括： 黄芪 3-30g The weight content of each component of the present invention per 200 ml of beverage includes: astragalus 3-30g
丹参 3— 30g Salvia 3— 30g
猕猴桃原汁 20-60g Kiwi Juice 20-60g
维生素 A 50 o0-2000国际单位 Vitamin A 50 o0-2000 IU
维生素 c Vitamin c
维生素 E 50— lOOmg Vitamin E 50— lOOmg
维生素 2— 5mg Vitamin 2— 5mg
锌 5— 15mg Zinc 5-15mg
其余为水。 The rest is water.
本发明的饮料中为增加口感，可根据口味和需要加入糖，所述 糖包括白糖，蛋白糖或其它甜味剂，所加数量，根据需要而定，如根 据饮者对饮料的热量需求等制成高热量饮料和低热量饮料，还可向 本发明饮料中加入一定量蜂蜜等饮料领域中常用的添加剂，这是本 领域技术人员熟知的。 To increase the taste in the beverage of the present invention, sugar can be added according to taste and needs. The sugar includes white sugar, protein sugar or other sweeteners, and the added amount is determined as needed, such as according to the calorie requirements of the drinker. It is well known to those skilled in the art to make high-calorie beverages and low-calorie beverages, and to add a certain amount of additives commonly used in the beverage field such as honey to the beverages of the present invention.
优逸地，所述各組份含量如下（以 200ml饮料计）： Youyidi, the content of each component is as follows (based on 200ml beverage):
2- 10g 2- 10g
2- 10g 2- 10g
20— 50g 20— 50g
500- 1500国际单位 500- 1500 International Units
75— lOOmg 75- lOOmg
75— lOOmg 75- lOOmg
2— 4mg 2—4mg
5— 10mgo 5— 10mg o
本发明的保健饮料，可按下述工艺制备： The health drink of the present invention can be prepared according to the following process:
a.将黄芪和丹参切碎，加入 10倍的蒸馏水，煎煮到所加黄芪和 丹参重量的 2倍量，加入 9倍量的 95%的 醇，静置 48小时，过滤
浓缩得 1 ： 1浓缩液； a. Chop Astragalus and Danshen into pieces, add 10 times distilled water, and cook to 2 times the weight of added Astragalus and Danshen, add 9 times the amount of 95% alcohol, let stand for 48 hours, and filter Concentrated to get 1: 1 concentrated solution;
b. 新鲜猕猴桃洗净去皮，经磨浆机磨成浆，离心沉淀，过滤得 澄清原汁； b. Fresh kiwi is washed and peeled, ground into a pulp by a refiner, centrifuged and precipitated, and filtered to obtain a clear raw juice;
c.将步骤 a和 b产物混合，加入所需量维生素 A，C，E和 以 及锌，再加入所需水混合均勻，以及根据需要加入糖、蜂蜜等添加 剂，消毒即得本发明的保健饮料。 c. Mixing the products of steps a and b, adding the required amounts of vitamins A, C, E and zinc, and adding the required water to mix well, and adding additives such as sugar and honey as needed, and sterilizing to obtain the health drink of the present invention. .
所述消毒方法可以是高温消毒，或伦琴射线辐射或徵波消毒。 以下用具体实施例对本发明进行更详细地描述。 实施例 組成 含量 The disinfection method may be high temperature disinfection, or Roentgen ray radiation or sign wave disinfection. Hereinafter, the present invention will be described in more detail with specific examples. Example Composition Content
黄芪 4g Astragalus 4g
丹参 4g Salvia 4g
猕猴挑 50g Macaque pick 50g
维生素 A 800国 ί示单位 Vitamin A 800 countries
维生素 c 80mg Vitamin c 80mg
维生素 E 75mg Vitamin E 75mg
维生素 ¾ 4mg Vitamin ¾ 4mg
硫酸锌 lOmg (按含锌量计） Zinc sulfate lOmg (based on zinc content)
将所述量的黄芪和丹参切碎，加入 80g蒸馆水，煎煮到 20g左 右，加入 95%的 醇 72g，静置 48小时，过滤，浓缩成 1 ： 1的浓缩 液。 The amount of astragalus and salvia was shredded, 80g of steamed water was added, and it was cooked to about 20g, and 72g of 95% alcohol was added, left for 48 hours, filtered, and concentrated to a 1: 1 concentrated solution.
所述量的猕猴桃洗净去皮，经麿浆机麿成浆，离心沉淀，过滤 得澄清原汁； The amount of kiwi is washed and peeled, mashed into a pulp by a masher, centrifuged, and filtered to obtain a clear raw juice;
用适量蒸馆水将所述量的维生素与疏酸锌分别溶解，与上述步 骤所得的产物混合，摇匀，加入蒸馏水至 200毫升，经伦琴射线辐射 消毒。 实施例 2
组成 含量 Dissolve the amount of vitamins and zinc sulphate with an appropriate amount of steamed water, mix with the product obtained in the above step, shake well, add distilled water to 200 ml, and sterilize by roentgen radiation. Example 2 Composition content
黄芪 5g Astragalus 5g
丹参 5g Salvia 5g
猕猴祧 25g Macaque pheasant 25g
维生素 A 750国]1示单位 Vitamin A 750 countries] 1 display unit
维生素 c 75mg Vitamin c 75mg
维生素 E 50mg Vitamin E 50mg
维生素 5mg Vitamin 5mg
硫酸锌 8mg (以锌含量计） Zinc sulfate 8mg (based on zinc content)
按实施例 1相同的方法制得 200ml本发明饮料 实施例 3 组成 含量 200ml of the beverage of the present invention was prepared in the same manner as in Example 1.
黄芪 4g Astragalus 4g
丹参 5g Salvia 5g
猕猴桃原汁 30g Kiwi Juice 30g
蜂蜜 4g Honey 4g
维生素 A 600囯际单位 Vitamin A 600 IU
维生素 c 40mg Vitamin c 40mg
维生素 E 20mg Vitamin E 20mg
维生素 5mg Vitamin 5mg
硫酸锌 8mg (以锌含量计） Zinc sulfate 8mg (based on zinc content)
蛋白糖 250g 250g
将上述成份以类似于实施 1的方法制得 200ml本发明饮料
200ml of the beverage of the present invention is prepared by the above-mentioned ingredients in a similar manner to that in Embodiment 1.
Claims
权利要求书 Claim
1.保健饮料，其特征是其中含有黄芪和丹参。 1. A health drink characterized by containing astragalus and salvia.
2.权利要求 1的饮料，其特征是其中含有猕猴桃原汁，多种维生素 和锌。 The beverage according to claim 1, characterized in that it contains raw kiwi juice, multivitamins and zinc.
3.权利要求 2的饮料，其特征是所述维生素为维生素 A，C，E和 。 The beverage according to claim 2, characterized in that said vitamins are vitamins A, C, E and.
4.权利要求 1或 2或 3的饮料，其特征是以 200ml饮料计，各組份 的組成包括： Ο ο The beverage according to claim 1 or 2 or 3, characterized in that it is based on a 200ml beverage, and the composition of each component includes: Ο ο
黄芪 3— 30g Astragalus 3— 30g
Ο Ο
丹参 3-30g Salvia 3-30g
猕猴桃原汁 Kiwi Juice
维生素 A 500〜2000国际单位 Vitamin A 500 ~ 2000 International Units
维生素 c Vitamin c
维生素 E 50— lOOmg Vitamin E 50— lOOmg
维生素 ¾ Vitamin ¾
锌 5一 15mg Zinc 5-15mg
其余为水。 The rest is water.
L利要求 4的饮料，其特征是各組份的組成包括: The beverage of claim 4 is characterized in that the composition of each component includes:
黄芪 4g Astragalus 4g
丹参 4g Salvia 4g
猕猴桃原汁 50g Kiwi Juice 50g
维生素 A 800国际单位 Vitamin A 800 IU
维生素 c 80mg Vitamin c 80mg
维生素 E 75mg Vitamin E 75mg
维生素 B6 4mg Vitamin B 6 4mg
锌 10mge Zinc 10mg e
6.饮料制备方法，其特征是所述方法包括步骤： 6. A beverage preparation method, characterized in that the method comprises the steps:
a.将一定量的黄芪和丹参切碎，加入 10倍左右蒸馆水，煎煮到 所加黄芪和丹参重量的 2倍量，再加入 9倍量的 95% 醇，静置，
过滤，浓缩液； a. A certain amount of astragalus and salvia are shredded, add about 10 times the steaming water, and cook to 2 times the weight of the astragalus and salvia added, and then add 9 times the amount of 95% alcohol and let stand Filtration, concentrate
b.将猕猴桃洗净去皮，经磨浆机磨成浆，离心沉淀，过滤得澄清 原汁； b. Wash and peel the kiwi fruit, grind it into a pulp by a refiner, centrifuge and precipitate, and filter to obtain a clear raw juice;
c.将步骤 a和 b产物混合，加入需要量的维生素 A、C、E、B6和 硫駿锌，再加入适量水混合均匀，消毒。
c. Mix the products of steps a and b, add the required amounts of vitamins A, C, E, B 6 and sulphur zinc, and then add an appropriate amount of water to mix and disinfect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU51412/96A AU5141296A (en) | 1995-04-03 | 1996-04-03 | Health beverage |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95103027A CN1052148C (en) | 1995-04-03 | 1995-04-03 | "Zhongniankang" beverage for health of middle aged people |
| CN95103027.2 | 1995-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1996031132A1 true WO1996031132A1 (en) | 1996-10-10 |
Family
ID=5074560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN1996/000022 WO1996031132A1 (en) | 1995-04-03 | 1996-04-03 | Health beverage |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1052148C (en) |
| AU (1) | AU5141296A (en) |
| WO (1) | WO1996031132A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002043506A2 (en) * | 2000-12-01 | 2002-06-06 | N.V. Nutricia | Cholesterol lowering supplement |
| CN112493316A (en) * | 2020-08-10 | 2021-03-16 | 浙江李子园食品股份有限公司 | Health-care milk beverage and preparation method thereof |
| CN115245190A (en) * | 2021-02-26 | 2022-10-28 | 王秀平 | Composition for improving immunity and preparation method thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050035C (en) * | 1996-09-06 | 2000-03-08 | 南京铁道医学院 | Method for producing nutritive health-care honey |
| CN100334976C (en) * | 2005-07-11 | 2007-09-05 | 谭金镜 | Beverage |
| CN101390637B (en) * | 2008-10-20 | 2012-11-21 | 湖南老爹农业科技开发股份有限公司 | Process technique of kiwi root beverage |
| CN102048214B (en) * | 2009-10-27 | 2013-04-03 | 吕学栋 | Compound thioctic acid beverage |
| CN103549576A (en) * | 2013-10-27 | 2014-02-05 | 胡丽萍 | Kiwi-fruit juice |
| WO2022197292A1 (en) * | 2021-03-16 | 2022-09-22 | Guo Lifeng | An herbal supplement drink for improving immunity |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056802A (en) * | 1991-07-08 | 1991-12-11 | 郭永录 | Miner's beverage and preparation method thereof |
| CN1064194A (en) * | 1992-04-17 | 1992-09-09 | 王崇伟 | The preparation method of astragalus root and wolfberry fruit health keeping tea |
| CN1075068A (en) * | 1993-02-15 | 1993-08-11 | 陈长义 | The preparation method of health drink " Triratna beneficence tea " |
| CN1080489A (en) * | 1992-06-26 | 1994-01-12 | 于卫红 | A kind of manufacture method of health beverage |
| CN1099234A (en) * | 1993-08-27 | 1995-03-01 | 湖南常德肉类联合加工厂 | Yangtao nectar and its making process |
| CN1099931A (en) * | 1993-09-09 | 1995-03-15 | 苏贵春 | Membranous milk vetch root tea and its producing process |
| CN1100608A (en) * | 1993-09-25 | 1995-03-29 | 许丽霞 | Health-care beverage and its prodn. method |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1071581A (en) * | 1991-10-19 | 1993-05-05 | 孙明君 | The compound method of Antiheptitic " Ganyanling " |
-
1995
- 1995-04-03 CN CN95103027A patent/CN1052148C/en not_active Expired - Fee Related
-
1996
- 1996-04-03 AU AU51412/96A patent/AU5141296A/en not_active Abandoned
- 1996-04-03 WO PCT/CN1996/000022 patent/WO1996031132A1/en active Application Filing
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056802A (en) * | 1991-07-08 | 1991-12-11 | 郭永录 | Miner's beverage and preparation method thereof |
| CN1064194A (en) * | 1992-04-17 | 1992-09-09 | 王崇伟 | The preparation method of astragalus root and wolfberry fruit health keeping tea |
| CN1080489A (en) * | 1992-06-26 | 1994-01-12 | 于卫红 | A kind of manufacture method of health beverage |
| CN1075068A (en) * | 1993-02-15 | 1993-08-11 | 陈长义 | The preparation method of health drink " Triratna beneficence tea " |
| CN1099234A (en) * | 1993-08-27 | 1995-03-01 | 湖南常德肉类联合加工厂 | Yangtao nectar and its making process |
| CN1099931A (en) * | 1993-09-09 | 1995-03-15 | 苏贵春 | Membranous milk vetch root tea and its producing process |
| CN1100608A (en) * | 1993-09-25 | 1995-03-29 | 许丽霞 | Health-care beverage and its prodn. method |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002043506A2 (en) * | 2000-12-01 | 2002-06-06 | N.V. Nutricia | Cholesterol lowering supplement |
| WO2002043506A3 (en) * | 2000-12-01 | 2002-10-03 | Nutricia Nv | Cholesterol lowering supplement |
| US6933291B2 (en) | 2000-12-01 | 2005-08-23 | N.V. Nutricia | Cholesterol lowering supplement |
| CN112493316A (en) * | 2020-08-10 | 2021-03-16 | 浙江李子园食品股份有限公司 | Health-care milk beverage and preparation method thereof |
| CN115245190A (en) * | 2021-02-26 | 2022-10-28 | 王秀平 | Composition for improving immunity and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5141296A (en) | 1996-10-23 |
| CN1052148C (en) | 2000-05-10 |
| CN1120412A (en) | 1996-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101593618B1 (en) | Composition for improving bioavailability of saponin | |
| CN1227495A (en) | Compositions of plant carbohydrates as dietary supplements | |
| CN109939143A (en) | A kind of Chinese medicine composition and preparation method thereof for hypoglycemic control complication | |
| RU2489934C2 (en) | Method for production of biologically active products of brown algae and fruits | |
| WO1996031132A1 (en) | Health beverage | |
| CN101396115A (en) | Xylo-oligosaccharide stomach-invigorating intestine-moisturizing oral liquid and preparation method thereof | |
| US20080124318A1 (en) | Algae supplement and treatment method | |
| CN103099842A (en) | Soft capsule helpful for increasing bone density and preparation method thereof | |
| CN108042786A (en) | A kind of compound oral drink of giant salamander polypeptide powder for being used to increase bone density | |
| KR20160059137A (en) | MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
| WO1995018626A1 (en) | A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof | |
| CN101244157A (en) | Natural plants extract, preparation method and application thereof | |
| WO2002011744A1 (en) | A strong antioxidant composite capsule containing grape seed extract opc and process for producing the same | |
| KR101095357B1 (en) | Processed Ginseng | |
| CN109043249A (en) | A kind of blueberry L-arabinose composite beverage underflow | |
| CN108850354A (en) | A kind of anti-aging return of spring tea-drinking dissipates and preparation method thereof | |
| CN1840000A (en) | Nutrition oral liquor | |
| CN109157548B (en) | Composition with functions of resisting fatigue and tonifying yang and preparation method thereof | |
| KR100628539B1 (en) | Yogurt composition for the control of a blood pressure | |
| KR102132537B1 (en) | Platycodon grandiflorum Liquid composition for stick-type container having increased ginsenosides of human body absorption type, and preparation method thereof | |
| CN104837336B (en) | Saltant type tomato and its purposes for preventing increased weight and/or treatment obesity-related disease | |
| CN112076292A (en) | Powder with functions of enhancing immunity and regulating kidney yin deficiency and preparation method thereof | |
| CN113349380A (en) | A renal function improving agent containing Concha Ostreae compound peptide and its preparation method | |
| KR20040081933A (en) | Bio-Fresh Ginseng(For Diabetic Patient) Tea | |
| CN110089754A (en) | Liver and gallbladder health care product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| 122 | Ep: pct application non-entry in european phase |